000 | 01955 a2200349 4500 | ||
---|---|---|---|
001 | 1315353474 | ||
005 | 20250317111637.0 | ||
008 | 250312042017xx 252 eng | ||
020 | _a9781315353470 | ||
037 |
_bTaylor & Francis _cGBP 47.99 _fBB |
||
040 | _a01 | ||
041 | _aeng | ||
072 | 7 |
_aPD _2thema |
|
072 | 7 |
_aTBN _2thema |
|
072 | 7 |
_aMKG _2thema |
|
072 | 7 |
_aPS _2thema |
|
072 | 7 |
_aPD _2bic |
|
072 | 7 |
_aTBN _2bic |
|
072 | 7 |
_aMMG _2bic |
|
072 | 7 |
_aPS _2bic |
|
072 | 7 |
_aMED071000 _2bisac |
|
072 | 7 |
_aSCI010000 _2bisac |
|
072 | 7 |
_aSCI013000 _2bisac |
|
072 | 7 |
_aTEC059000 _2bisac |
|
072 | 7 |
_a615.19 _2bisac |
|
100 | 1 | _aHuiliang Cao | |
245 | 1 | 0 |
_aSilver Nanoparticles for Antibacterial Devices _bBiocompatibility and Toxicity |
250 | _a1 | ||
260 |
_bCRC Press _c20170518 |
||
300 | _a478 p | ||
520 | _bSince the potential toxicity of silver nanoparticles (Ag NPs) has raised serious concerns in the biomaterials and biomedical engineering community, Silver Nanoparticles for Antibacterial Devices: Biocompatibility and Toxicity brings together the synthesis, the physicochemical properties and the biological actions of Ag NPs, as well as the clinical demands for fabricating antibacterial medical devices, discussing how to suppress the side effects of nanomaterials and how to impart to them the selective toxicity. This book presents the two primary paradigms that have emerged in probing the antibacterial applications of Ag NPs, i.e. the active attacking releasing way and the conservative defending approach by taking advantage of various short-range actions; it shows readers how the ways in which Ag NPs have behaved can be engineered purposively. With contributions from leading international experts and extensive references listed in each chapter, this volume provides the general principles on controlling the physicochemical behaviors of nanomaterials and managing their toxicity risks. | ||
999 |
_c7233 _d7233 |